Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Lifts Tamiflu Shipping Restrictions

This article was originally published in The Pink Sheet Daily

Executive Summary

Firm is responding to a CDC health alert recommending against use of two older antivirals due to resistance.

You may also be interested in...



Roche Tamiflu “Re-Launch” Seeks To Bolster Seasonal Demand

Market research found that unprompted awareness of the antiviral was low, despite having strong publicity for use in pandemic preparedness.

Roche Tamiflu “Re-Launch” Seeks To Bolster Seasonal Demand

Market research found that unprompted awareness of the antiviral was low, despite having strong publicity for use in pandemic preparedness.

Tamiflu Federal Stockpile Order Spikes For 2006

HHS increases its oseltamivir order from 20 mil. treatment courses to 46 mil.

Topics

UsernamePublicRestriction

Register

LL1135307

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel